Table 2 Profile of Moroccan patients with X-ALD
From: Management of X-linked adrenoleukodystrophy in Morocco: actual situation
Case no | Age at onset | Initial symptom | Age at dignosis (interval) | Phenotype |
|---|---|---|---|---|
1 | – | – | 25–30 | Asymptomatic |
2 | 6 | Hyperactivity | 5–10 | Asymptomatic |
3 | – | – | 25–30 | Asymptomatic |
4 | 7 | Isolation | 5–10 | CCALD |
5 | 7 | Diminution of school performances | 5–10 | CCALD |
6 | 5 | – | 5–10 | Asymptomatic |
7 | – | – | 35–40 | Asymptomatic |
8 | 6 | Behavioral changes | 5–10 | CCALD |
9 | 4 | – | 3–5 | Asymptomatic |
10 | 2 | Skin pigmentation | 3–5 | CCALD |
11 | 5 | Paraparesis | 5–10 | CCALD |
12 | 6 | Digestive symptoms | 5–10 | CCALD |
13 | 6 | Gait disturbance | 5–10 | CCALD |
14 | – | – | 40–45 | Asymptomatic |
15 | 6 | Gait disturbance | 5–10 | CCALD |
16 | – | – | 10–15 | Asymptomatic |